Clinical TrialsSearch results
Number of results: 778
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Recruiting
- A Study to Evaluate the Efficacy and Safety of VR-205 in Primary IgA Nephropathy Patients at Risk of Developing End-Stage Renal Disease (ESRD)
- Primary IgA Nephropathy
- Itoigawa Suguru
- 2024-04-24
Recruiting
- A Study to Learn About a New Medicine Called ARV-471 (PF-07850327) in People Who Have Advanced Metastatic Breast Cancer.
- ER+/HER2 Advanced Breast Cancer
- Kawai Norisuke
- 2023-02-22
Recruiting
- A study to test different doses of BI 765049 alone and in combination with ezabenlimab in Asian people with advanced cancer (solid tumours) positive for B7-H6
- B7-H6-positive GC, CRC, PDAC, HCC, HNSCC, or NSCLC patients
- Hagimori Kenta
- 2024-01-26
Recruiting
- A study to test whether spesolimab helps people with skin disease called Netherton syndrome
- Netherton Syndrome
- Taguchi Aya
- 2023-03-21
Recruiting
- Addition of binimetinib after refractory to encorafenib and cetuximab in patients with BRAF V600E-mutant metasta
tic colorectal cancer
- Unresectable, advanced or recurrent colorectal cancer with BRAF V600E mutation
- Bando Hideaki
- 2022-01-01
Recruiting
- Amyloid Brain PET study
- Dementia
- Takahashi Miwako
- 2023-12-04
Recruiting
- An exploratory intervention study of renal rehabilitation for patients with conservative chronic kidney disease
- chronic kidney disease
- Aizawa Masashi
- 2022-06-25
Recruiting
- An exploratory randomized controlled trial of the clinical efficacy of anamorelin hydrochloride in patients after radical surgery for upper gastric cancer and esophagogastric junction cancer - a phase II trial
- Gastric cancer, Esophagogastric junction cancer
- Matsumoto Yasunori
- 2024-02-20
Recruiting
- An investigational study of chemoradiosensitivity prediction with genetic profiling of esophageal biopsy for squamous cell carcinoma of the esophagus
- Esophageal cancer
- University of Toyama
- 2007-02-01
Recruiting
- An open label phase 1b/2 study to evaluate efficacy and safety of trastuzumab deruxtecan (T-DXd) plus nivolumab plus capecitabin plus oxaliplatin for patients with HER2 low gastric and gastroesophageal junction adenocarcinoma
- HER2 low gastric, gastroesophageal junction, or esophageal adenocarcinoma
- Kohei Shitara
- 2023-11-25